The purinosome is a multienzyme complex composed by the enzymes active in de novo purine synthesis (DNPS) that cells transiently assemble in their cytosol upon depletion or increased demand of purines. The process of purinosome formation has thus far been demonstrated and studied only in human epithelial cervical cancer cells (HeLa) and human liver carcinoma cells (C3A) transiently expressing recombinant fluorescently labeled DNPS proteins. Using parallel immunolabeling of various DNPS enzymes and confocal fluorescent microscopy, we proved purinosome assembly in HeLa, human hepatocellular liver carcinoma cell line (HepG2), sarcoma osteogenic cells (Saos-2), human embryonic kidney cells (HEK293), human skin fibroblasts (SF) and primary human keratinocytes (KC) cultured in purine-depleted media. Using the identical approach, we proved in cultured skin fibroblasts from patients with AICA-ribosiduria and ADSL deficiency that various mutations of ATIC and ADSL destabilize to various degrees of purinosome assembly and found that the ability to form purinosomes correlates with clinical phenotypes of individual ADSL patients. Our results thus shown that the assembly of functional purinosomes is fully dependent on the presence of structurally unaffected ATIC and ADSL complexes and presumably also on the presence of all the other DNPS proteins. The results also corroborate the hypothesis that the phenotypic severity of ADSL deficiency is mainly determined by structural stability and residual catalytic capacity of the corresponding mutant ADSL protein complexes, as this is prerequisite for the formation and stability of the purinosome and at least partial channeling of succinylaminoimidazolecarboxamide riboside-ADSL enzyme substrates-through the DNPS pathway.
INTRODUCTION
Purine nucleotides are essential components of a number of vital biomolecules, such as nucleic acids, coenzymes (NAD, NADP, FAD and coenzyme A), signaling molecules [e.g. cyclic adenosine monophosphate (cAMP)] and chemical energy transfer molecules (ATP). The pool of purine nucleotides is the result of de novo synthesis, recycling in the purine nucleotide cycle (PNC) and the salvage pathway, degradation and urinary excretion. To meet the highly dynamic requirements for purine nucleotides in dividing, differentiating and fully differentiated cells during development and throughout the life, these pathways must be precisely regulated and coordinated.
De novo purine synthesis (DNPS) starts with phosphoribosyl pyrophosphate (PRPP) and generates inosine 5 ′ -monophosphate (IMP), which is further converted to AMP and guanosine monophosphate. DNPS requires 10 enzymatic steps to generate IMP. This process is catalyzed by six enzymes in eukaryotes-PRPP amidotransferase (PPAT) (EC 2.4.2.14), trifunctional phosphoribosylglycinamide formyltransferase (EC 2. (1) . Efficiency of DNPS at such low concentrations of individual intermediates is ensured by the dynamic assembly and disassembly of the cytosolic multienzyme complex-the purinosome (2,3) (Fig. 1) . The biological importance of DNPS, the cytotoxic properties of DNPS intermediates and thus the vital role of a fully functional purinosome in humans are best demonstrated by the devastating neurologic diseases resulting from two genetic defects of DNPS-AICA-ribosiduria (OMIM #608688) (4) and adenylosuccinate lyase deficiency (dADSL) (OMIM #103050) (5, 6) .
AICA-ribosiduria is caused by mutations in the ATIC gene encoding ATIC, which catalyzes the last two reactions of DNPS; there has been one patient reported (4) . ATIC deficiency in this individual led to the accumulation of aminoimidazolcarboxamide riboside (AICAr), the dephosphorylated substrate of ATIC as well as to the accumulation of dephosphorylated substrates of ADSL enzyme-succinylaminoimidazolecarboxamide riboside (SAICAr) and succinyladenosine (S-Ado) in the body fluids.
ADSL deficiency is caused by mutations in the ADSL gene and has been identified in more than 70 patients (7) (8) (9) (10) (11) (12) (13) (14) . For summary of reported patients and causal mutations, see ADSL mutation database (http://www1.lf1.cuni.cz/ udmp/adsl). ADSL deficiency leads to the accumulation of the dephosphorylated ADSL enzyme substrates SAICAr and S-Ado in body fluids of affected individuals. The clinical severity spectrum is variable, and it has been observed to correlate with different values of the S-Ado and SAICAr concentration ratios in the cerebrospinal fluid (the S-Ado/ SAICAr ratio) (8, 15) .
In our previous work, we explored the clinical and biochemical heterogeneity of ADSL and individual differences in S-Ado/SAICAr ratios by detailed biochemical studies of single recombinant mutant ADSL proteins (16) as well as homomeric ADSL complexes (composed of a single mutant protein) and genotype-specific heteromeric ADSL complexes (composed from two genotype-specific mutant proteins) (17) . We found that the phenotypic severity in ADSL deficiency correlates with structural stability and residual enzymatic activity of the corresponding mutant ADSL complexes. Based on these results, we hypothesized that the structurally unstable mutant ADSL complexes may affect the assembly of the purinosome in vivo, reduce the efficiency of substrate channeling through the DNPS pathway and therefore lead to more severe phenotypes associated with low S-Ado/ SAICAr ratios (17) .
The purinosome is a multienzyme complex of the DNPS enzymes that cells transiently assemble in their cytosol upon depletion or increased demand of purines (2) . The process of purinosome formation has thus far been demonstrated and studied only in HeLa and human C3A liver carcinoma cells transiently expressing recombinant fluorescently labeled DNPS proteins (2, (18) (19) (20) , and the existence of purinosomes under in vivo conditions, e.g. in non-transfected cells, has not yet been demonstrated directly.
In this work, we therefore studied purinosome assembly in various carcinoma and normal cell lines and investigated whether and to what extent the two known genetic defects of DNPS-AICA-ribosiduria and ADSL deficiency-affect the formation and stability of the purinosome in cultured skin fibroblasts. We further explored whether biochemical changes could be correlated with clinical phenotypes of individual ADSL patients.
RESULTS
Purine depletion stimulates purinosome formation in carcinoma cell lines, cultured human skin fibroblasts and primary human keratinocytes
To detect purinosome assembly under in vivo conditions, we cultured human epithelial cervical cancer cells (HeLa), human hepatocellular liver carcinoma cell line (HepG2), sarcoma osteogenic cells (Saos-2), human embryonic kidney 293 cells (HEK293), human skin fibroblasts (SF) and primary human keratinocytes (KC) in purine-rich or purinedepleted media. After 24 h of incubation (HeLa, HepG2, Saos-2 and HEK293 cells) and 72 h of incubation (skin fibroblasts and keratinocytes), we performed parallel immunolabeling of the two most functionally distant proteins of DNPS -PPAT (step 1) and ATIC (steps 9 and 10) ( Fig. 1 ) and analyzed their cellular localization using confocal fluorescent microscopy ( Figs 2 and 3) .
In all the cell types cultured in the purine-rich medium, both proteins showed either fine granular (Fig. 2D , E, J and K) or diffuse intracellular staining ( Similar staining patterns and signal overlaps were observed using parallel immunostaining of other DNPS proteins -PPAT and ADSL, GART and ADSL (data not shown).
Purinosome formation is affected in cultured skin fibroblasts from patients with genetic defects of ATIC and ADSL To see whether mutations of the ATIC and ADSL genes affect intracellular compartmentalization of DNPS proteins in vivo and determine to what extent this may be correlated with phenotype severity in patients with ADSL deficiency (e.g. different S-Ado/SAICAr ratios), we investigated purinosome formation in skin fibroblasts from the only identified patient with AICA-ribosiduria and from nine patients with ADSL deficiency representing three major phenotypic forms of the disease-the neonatal form characterized by fatal neonatal encephalopathy and S-Ado/SAICAr ratios ,1, the severe childhood form (type I) characterized by severe psychomotor retardation and S-Ado/SAICAr ratios 1 and the mild form (type II) characterized by psychomotor retardation or hypotonia and S-Ado/SAICAr ratios .2. To detect purinosome formation, we cultured skin fibroblasts in the purine-depleted medium as described above and we immunolabeled various combinations of DNPS proteins.
In AICA-ribosiduria fibroblasts (Fig. 4) , we observed fine granular staining of ADSL ( Fig. 4A and T) , PPAT (Fig. 4G , M and S) and GART ( Fig. 4N ) with staining intensity comparable with control fibroblasts. Staining of ATIC was almost undetectable ( Fig. 4B and H) and hence no signal overlap between ATIC and other proteins, ADSL and PPAT, was detected ( Fig. 4C and I ). Further image analysis showed a decrease in the overlaps of PPAT and GART staining signals (Fig. 4O) , as well as of PPAT and ADSL staining signals (Fig. 4U) , compared with healthy control fibroblasts ( Fig. 4R and X, respectively).
In ADSL deficient fibroblasts, the staining signal of ADSL was almost undetectable in patients with the neonatal form of the disease ( The staining signal of GART in all analyzed samples was mostly finely granular with staining intensity comparable with the healthy control (Fig. 6A1 -A11 ). Staining intensity of PPAT was also mostly finely granular, with staining intensity comparable with control ( Fig. 7A1-A10) . . Purinosome formation is affected in skin fibroblasts from the patient with AICA-ribosiduria cultured in the purine-depleted medium. In skin fibroblasts from the patient with AICA-ribosiduria, ATIC was not detected (B and H), whereas ADSL (A and T), PPAT (G, M and S) and GART (N) were present in a form of fine granules and staining intensities comparable with control fibroblasts. Due to the loss of ATIC, no signal overlap between ATIC and ADSL or PPAT was detected (C and I). Affection of purinosome assembly is evident from the low coefficients of the fluorescent signal overlaps of PPAT and GART (O) as well as of PPAT and ADSL (U). The values are transformed to a pseudo-color scale which is shown at right bottom in the corresponding lookup table. Figure 5 . Expression of ADSL and ATIC and purinosome assembly in skin fibroblasts from the patients with ADSL deficiency cultured in the purine-depleted medium. ADSL (A1-A11), ATIC (B1-B11) and coefficients of their fluorescent signals demonstrating purinosome assembly (C1-C11) in control and patients' skin fibroblasts. In control skin fibroblasts, ADSL (A1) and ATIC (B1) were present in a form of fine granules and their fluorescent signals showed a high degree of overlap suggestive of purinosome assembly (C1). In skin fibroblasts from the patients with the neonatal form of the disease, ADSL was either undetectable (A2-A4) or its amount was decreased (A5). ATIC was decreased accordingly (B2-B5) and no fluorescent signal overlap between ADSL and ATIC was detected (C2-C5). In skin fibroblasts from the patients with the type I form of the disease, ADSL was decreased (A6-A8), ATIC showed mostly diffuse intracellular staining (B6-B8) and no fluorescent signal overlap between ADSL and ATIC was detected (C6-C8). In skin fibroblasts from the patients with the type II form of the disease, ADSL (A9-A11) and ATIC (B9-B11) were present in a form of fine granules and their fluorescent signals showed some degree of overlap (C9-C11). This was, however, much lower than in control skin fibroblasts (C1). The values of fluorescent signal overlaps are transformed to a pseudo-color scale which is shown at right bottom in the corresponding lookup table. Figure 6 . Expression of GART and ADSL and purinosome assembly in skin fibroblasts from the patients with ADSL deficiency cultured in the purine-depleted medium. GART (A1 -A11), ADSL (B1-B11) and coefficients of their fluorescent signals demonstrating purinosome assembly (C1-C11) in control and patients' skin fibroblasts. In control skin fibroblasts, GART (A1) and ADSL (B1) were present in a form of fine granules and their fluorescent signals show a high degree of overlap suggestive of purinosome assembly (C1). In skin fibroblasts from the patients with the neonatal form of the disease, GART was present in a form of fine granules (A2-A5), ADSL amount was reduced (B2-B5) and no fluorescent signal overlap between GART and ADSL was detected (C2-C5). In skin fibroblasts from the patients with the type I form of the disease, GART was present in a form of fine granules (A6-A8), ADSL amount was decreased (B6-B8) and no fluorescent signal overlap between GART and ADSL was detected (C6-C8). In skin fibroblasts from the patients with the type II form of the disease, GART (A9-A11) and ADSL (B9-B11) were present in a form of fine granules and their fluorescent signals showed some degree of overlap (C9-C11). This was, however, much lower than in control skin fibroblasts (C1). The values of fluorescent signal overlaps are transformed to a pseudo-color scale which is shown at right bottom in the corresponding lookup table.
DISCUSSION
In this work we build upon the seminal findings of An et al.
(2), who described the purinosome, a transient multienzyme complex that appears to be dynamically assembled and disassembled by actual need and availability of purines. Following their experiments investigating the intracellular localization of transiently expressed recombinant DNPS enzymes tagged with fluorescent proteins in cancer cells (2), we were first interested to address whether purinosome assembly occurs and is detectable also under in vivo conditions in cancer and normal cells.
We therefore investigated purinosome formation in several cell lines cultured in purine-rich and purine-depleted media and used commercially available antibodies to directly immunodetect various pairs of enzymes active along the DNPS pathway. To detect and quantitative spatial overlaps of two enzymes participating in DNPS and thus demonstrate purinosome formation, we used confocal microscopy and applied an established method of signal colocalization analysis based on single pixel overlap coefficient values (21) . Using this approach, we detected shared compartmentalization and their spatial overlaps suggestive of purinosome formation in 5% of carcinoma cells and embryonic cells and in 20% of human skin fibroblasts and keratinocytes. Purinosome structures were observed only in cells cultured in purine-depleted media, which is suggestive that this process is inherent to many, if not all, cell types that are in actual need of purines, e.g. in cells in the G1/S transition and during S-phase. Upon the detection of purinosome structures in control human skin fibroblasts, we further investigated to what extent the two known genetic defects of DNPS-AICA-ribosiduria and ADSL deficiency-affect the formation or stability of the purinosome in fibroblasts and whether this may be correlated with the phenotypic heterogeneity of ADSL deficiency, which is known to be associated with structural instability and residual enzymatic activity of the corresponding mutant ADSL complexes and altered S-Ado/SAICAr ratios in body fluids.
As the causal genetic defects often affect the amounts of the corresponding mutant protein in vivo, we studied the intracellular localization of various combinations of DNPS enzymes. Accordingly, in fibroblasts from AICA-ribosiduria, we observed a significant reduction in the mutated ATIC, which is in agreement with both instability of the (125 -129dupGG-GAT; 130-132delGCT) ATIC transcript (4) and the predicted structural impact of the Lys426Arg mutation on the folding stability of the tertiary structure of the ATIC (22) . The absence of ATIC clearly hindered purinosome assembly, as was apparent from the reduced fluorescent signal overlaps of otherwise normally present PPAT, GART and ADSL proteins in all cells. The absence of ATIC and resulting enzyme deficiency, together with altered purinosome formation, may thus explain both the accumulation of AICA-riboside (AICAR) in the patient's urine and the accumulation of AICAR and its derivatives in erythrocytes and fibroblasts (4) , and also the accumulation of SAICAr and S-Ado in a situation when the amount and activity of ADSL are normal.
In a series of fibroblasts from patients with ADSL deficiency, we confirmed that the amounts of ADSL correlate with the severity of the phenotype, as the ADSL protein was not detected in cases with the most severe neonatal fatal form of the disease, and that similar to AICA-ribosiduria the absence of ADSL protein hindered purinosome assembly. The assembly of functional purinosome structures thus seems to be fully dependent on the presence of structurally unaffected ATIC and ADSL complexes and presumably also on the presence of all the other DNPS proteins.
Our results have further shown that significant differences of purinosome assembly exist among individual cases with ADSL deficiency and that the ability to form purinosomes correlates with the severity of the phenotype. This finding corroborates the hypothesis that the phenotypic severity of ADSL deficiency is mainly determined by structural stability and residual catalytic capacity of the corresponding mutant ADSL protein complex, as this is prerequisite for the formation and stability of the purinosome and at least partial channeling of SAICA-ribotide (SAICAR) through the DNPS pathway (17, 23) . Partial channeling of intermediates through such structurally intact but catalytically less competent purinosomes would theoretically produce less SAICAR and more IMP, which could be converted at presumably relatively constant flux through PNC to S-AMP. This mechanism may then lead to differences in intracellular concentrations of SAICAR and S-AMP and result in altered S-Ado/SAICAr ratios measured in individual patients.
In summary, we proved the existence of purinosome structures in several types of cultured cells and showed that these structures are fully dependent on the presence of structurally intact ATIC and ADSL protein complexes and presumably also on the presence of all the other DNPS proteins.
We also showed that mutations affecting the structural stability of ADSL affect the assembly of the purinosome in vivo, reduce the effectiveness of substrate channeling through the DNPS pathway and thus result in more severe phenotypes associated with low S-Ado/ SAICAr ratios. Figure 7 . Expression of PPAT and ATIC and purinosome assembly in skin fibroblasts from the patients with ADSL deficiency cultured in the purine-depleted medium. PPAT (A1 -A10), ATIC (B1-B10) and coefficients of their fluorescent signals demonstrating purinosome assembly (C1-C10) in control and patients' skin fibroblasts. In control skin fibroblasts, PPAT (A1) and ATIC (B1) were present in a form of fine granules and their fluorescent signals show a high degree of overlap suggestive of purinosome assembly (C1). In skin fibroblasts from the patients with the neonatal form of the disease, PPAT was present in a form of fine granules (A2 -A5), ATIC showed either reduced (B2) or diffuse intracellular staining (B3-B5). No fluorescent signal overlap between PPAT and ATIC was detected (C2-C5). In skin fibroblasts from the patients with the type I form of the disease, PPAT (A6 and A7) and ATIC (B6 and B7) were present in a form of fine granules, and residual fluorescent signal overlap between PPAT and ATIC was detected (C6 and C7). In skin fibroblasts from the patients with the type II form of the disease, PPAT (A8-A10) and ATIC (B8-B10) were present in a form of fine granules and their fluorescent signals showed some degree of overlap in cases with Arg426His/Asp430Asn and Tyr114His/Arg190Gln mutations (C8 and C9). This was, however, lower than in control skin fibroblasts (C1). No fluorescent signal overlap between PPAT and ATIC was detected in case with the Arg303Cys/Arg303Cys mutation (C10). The values of fluorescent signal overlaps are transformed to a pseudo-color scale which is shown at right bottom in the corresponding lookup table.
MATERIALS AND METHODS

Cell culture
HepG2, HeLa, Saos-2, HEK 293, SF and KC were maintained in the Dulbecco's minimum essential medium (DMEM, Gibco, Invitrogen), supplemented with 10% fetal bovine serum (FBS) (Gibco, Invitrogen) and 1% penicillin/streptomycin (Sigma-Aldrich). The purine-rich media were enriched with 3 × 10 -5 M adenine. The purine-depleted media were supplemented with dialyzed 10% FBS and 1% penicillin/ streptomycin (Sigma-Aldrich). FBS was dialyzed according to An et al. (2) . The cells were seeded either in the purine-rich or in the purine-depleted medium. After 24 h for HeLa, HepG2, Saos-2 and HEK293 cells or after 72 h for skin fibroblasts and keratinocytes, the immunofluorescence labeling was performed.
Patients
Clinical data of nine ADSL patients with genotypes Tyr114His/Arg426His, Tyr114His/Glu376Asp (neonatal fatal form), Arg426His/Arg426His, Asp268Asn/Pro467Arg (type I. form), Arg426His/Asp430Asn, Tyr114His/Arg190Gln and Arg303Cys/Arg303Cys (type II. form) and of one patient with AICA-ribosiduria were described previously (4 -6,8,24) .
Immunofluorescence
For immunofluorescence labeling, the cells were grown on 70 mm 2 glass chamber slides (Lab-Tek w , Nalge Nunc International) for 24 or 72 h. The cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS), permeabilized in 0.1% TRITON, washed, blocked with 5% bovine serum albumin in PBS and incubated in a humidified chamber for 1 h at 378C with primary antibodies: rabbit polyclonal IgG anti-PPAT (Sigma-Aldrich), mouse polyclonal IgG anti-GART (Novus Biologicals), mouse monoclonal IgG anti-ADSL (Abnova Antibodies, Novus Biologicals), rabbit polyclonal IgG anti-ADSL (Atlas antibodies AB) and mouse monoclonal IgG anti-ATIC (Abcam Antibodies). For fluorescence detection, species appropriate secondary antibodies Alexa Fluor w 488 and 555 (Molecular Probes, Invitrogen) were used. Cell nuclei were labeled with DAPI (Sigma-Aldrich). Slides were mounted in the fluorescence mounting medium Immu-Mount (Shandon Lipshaw, Pittsburgh, PA, USA) and analyzed by confocal microscopy. All immunofluorescence experiments were repeated at least twice.
Image acquisition and analysis
Prepared slides were analyzed by confocal microscopy. XYZ images were sampled according to Nyquist criterion using TE2000E C1si laser scanning confocal microscope, Nikon PlanApo objective (60×, N.A.1.40), 405, 488 and 543 laser lines. Images were restored using a classic maximum likelihood restoration algorithm in the Huygens Professional Software (SVI, Hilversum, the Netherlands) (25) . The colocalization maps employing single pixel overlap coefficient values ranging from 0 to 1 (21) were created in the Huygens Professional Software. The resulting overlap coefficient values are presented as the pseudo-color scale which is shown in the corresponding lookup tables. Image analysis was performed on at least 10 cells from each cell type, and single experiments were repeated 3×. Conditions for the image acquisition were the same for all cells included to the experiment.
